Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

BUY
$0.22 - $0.96 $1,456 - $6,355
6,620 Added 8.55%
84,033 $40,000
Q4 2021

Feb 11, 2022

SELL
$0.88 - $1.78 $6,101 - $12,340
-6,933 Reduced 8.22%
77,413 $70,000
Q3 2021

Nov 12, 2021

BUY
$1.48 - $2.65 $7,089 - $12,693
4,790 Added 6.02%
84,346 $125,000
Q2 2021

Aug 13, 2021

SELL
$2.41 - $7.11 $127,821 - $377,100
-53,038 Reduced 40.0%
79,556 $199,000
Q1 2021

May 12, 2021

BUY
$4.7 - $7.17 $34,465 - $52,577
7,333 Added 5.85%
132,594 $804,000
Q4 2020

Feb 12, 2021

BUY
$2.95 - $11.04 $24,263 - $90,804
8,225 Added 7.03%
125,261 $745,000
Q3 2020

Nov 13, 2020

BUY
$9.37 - $12.06 $1,958 - $2,520
209 Added 0.18%
117,036 $1.27 Million
Q2 2020

Aug 13, 2020

BUY
$8.29 - $11.47 $387,242 - $535,786
46,712 Added 66.62%
116,827 $1.26 Million
Q1 2020

May 14, 2020

BUY
$6.44 - $11.32 $14,193 - $24,949
2,204 Added 3.25%
70,115 $626,000
Q4 2019

Feb 13, 2020

BUY
$5.26 - $9.6 $594 - $1,084
113 Added 0.17%
67,911 $651,000
Q2 2019

Aug 14, 2019

BUY
$4.33 - $6.54 $293,565 - $443,398
67,798 New
67,798 $427,000

About AVENUE THERAPEUTICS, INC.


  • Ticker ATXI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 4,127,720
  • Market Cap $8.13M
  • Description
  • Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was in...
More about ATXI
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.